focus -WSS

focus

author：explore 2025-08-04 03:43:24 - browse：2324

Since the pandemic, patients have become increasingly comfortable with getting their medications online. Direct-to-consumer telehealth has made it easy to schedule a virtual visit and get a script, sometimes within minutes, with prescriptions shipped to your doorstep.

Now, Big Pharma is ready to get in on the action.

In early January, Eli Lilly announced a platform that allows patients to access and fill prescriptions for its drugs online, timing the news to the availability of its obesity medication Zepbound. Using LillyDirect, patients click into a pipeline for their condition — obesity, diabetes, or migraine — and are routed to telehealth sites that can prescribe them one of Lilly’s drugs if they’re eligible. An integration with online pharmacy Truepill will deliver the meds.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Midwives could help bridge maternal health disparities in the U.S.

WSS

Assistant physicians can help address the primary care shortage

Florida Supreme Court upholds state's abortion ban

Overprescribed: High cost isn't America's only drug problem

Researchers test human milk's ability to repair gut microbiome

Transgender sports debate: Physicians say bans are health issue

Scientific mystery highlights the blind spots in genomics databases

hotspot

focus

leisure time

Wildfire smoke exposes gaps in outdoor worker protections

Trial using CRISPR to edit HIV out of cells disappoints

Bright Health sells Medicare Advantage business to Molina

The unintended consequences of overturning Roe v. Wade

Guidelines to prevent youth baseball injuries need more muscle

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Anesthesiologist group: stop taking Ozempic before surgery

Young boy dies in trial for Pfizer Duchenne gene therapy

In age of alternative facts, a scholarly course on calling out crap

Gut bacteria may contribute to kidney autoimmunity, study finds

knowledge

Trial using CRISPR to edit HIV out of cells disappoints

Neurocrine congenital adrenal hyperplasia trial succeeds

Scientists uncover potential path to treating deadly childhood tumor

Fed up with FDA, ALS advocates consider a take

Fed up with FDA, ALS advocates consider a take

Patients, doctors press FTC to beef up hospital merger scrutiny

hotspot

hotspot

Wikipedia

focus